Pharmaceuticals · Egypt
Top 10 Pharmaceuticals markets in Egypt
The fastest-growing and largest of the 20 sized Pharmaceuticals markets in Egypt, 2023 to 2033, with active clinical trials.
Top 10 Pharmaceuticals markets in EgyptThe fastest-growing and largest of the 20 sized Pharmaceuticals markets in Egypt, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $103 Mn | $1.1 Bn | 26.4% | 18 |
| 2 | Cell Based Immunotherapy | $47 Mn | $416 Mn | 24.5% | 218 |
| 3 | Cannabidiol (CBD) | $62 Mn | $331 Mn | 18.3% | 7 |
| 4 | Cannabis | $95 Mn | $384 Mn | 15% | 3 |
| 5 | Atopic Dermatitis Drugs | $31 Mn | $114 Mn | 13.7% | 2 |
| 6 | Oncology/Cancer Drugs | $496 Mn | $1.3 Bn | 9.9% | 256 |
| 7 | Anti-Aging | $247 Mn | $618 Mn | 9.6% | 13 |
| 8 | Diabetes Management | $218 Mn | $498 Mn | 8.6% | 72 |
| 9 | Alzheimer Drugs | $14 Mn | $31 Mn | 8.3% | 1 |
| 10 | Contraceptives Drugs | $71 Mn | $157 Mn | 8.3% | 1 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $496 Mn | $1.3 Bn | 9.9% | 256 |
| 2 | Anti-Aging | $247 Mn | $618 Mn | 9.6% | 13 |
| 3 | Diabetes Management | $218 Mn | $498 Mn | 8.6% | 72 |
| 4 | Gastrointestinal Drugs | $151 Mn | $273 Mn | 6.1% | 181 |
| 5 | Asthma & COPD Drugs | $139 Mn | $237 Mn | 5.5% | 28 |
| 6 | Biosimilars | $103 Mn | $1.1 Bn | 26.4% | 18 |
| 7 | Cannabis | $95 Mn | $384 Mn | 15% | 3 |
| 8 | HIV Drugs | $84 Mn | $170 Mn | 7.3% | 2 |
| 9 | Contraceptives Drugs | $71 Mn | $157 Mn | 8.3% | 1 |
| 10 | Cancer Supportive Care Drugs | $69 Mn | $127 Mn | 6.2% | 47 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Biosimilars grows fastest, at 26.4% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (24.5%).
Oncology/Cancer Drugs is the largest, worth about $496 Mn in 2023 and $1.3 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.
South Africa
Kenya